Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 10.94%37.06B | 5.92%139.94B | 3.73%106.41B | 4.09%66.82B | 0.65%33.41B | 16.11%132.12B | 19.78%102.59B | 29.67%64.2B | 48.96%33.19B | 145.74%113.79B |
| Operating income | 10.94%37.06B | 5.92%139.94B | 3.73%106.41B | 4.09%66.82B | 0.65%33.41B | 16.11%132.12B | 19.78%102.59B | 29.67%64.2B | 48.96%33.19B | 145.74%113.79B |
| Operating expenses | -3.94%-34B | -2.66%-98.65B | -3.25%-32.71B | -18.69%-96.1B | -30.90%-31.68B | |||||
| Gross profit | 340.63%3.06B | 19.69%7.76B | -53.95%694M | 38.63%6.49B | 178.33%1.51B | |||||
| Selling expenses | -13.55%-1.65B | -10.46%-4.36B | -10.36%-4.48B | -11.51%-2.09B | -6.52%-1.45B | -34.73%-3.95B | -29.81%-4.06B | -40.00%-1.88B | -56.18%-1.37B | -249.34%-2.93B |
| Administrative expenses | -8.32%-1.05B | ---- | -8.26%-3.01B | ---- | -13.93%-973M | ---- | -12.31%-2.78B | ---- | -7.96%-854M | ---- |
| Research and development expenses | 36.26%-58M | ---- | 64.82%-89M | ---- | -18.18%-91M | ---- | -16.06%-253M | ---- | 11.49%-77M | ---- |
| Profit from asset sales | 741.67%101M | ---- | 28.95%49M | ---- | 0.00%12M | ---- | 322.22%38M | ---- | 140.00%12M | ---- |
| Employee expense | ---- | -11.81%-29.69B | ---- | -11.06%-14.02B | ---- | -12.17%-26.55B | ---- | -14.84%-12.62B | ---- | -15.56%-23.67B |
| Depreciation and amortization | ---- | -4.69%-27.89B | ---- | -0.95%-13.33B | ---- | -6.40%-26.64B | ---- | -8.04%-13.2B | ---- | -14.81%-25.04B |
| Revaluation surplus | -2,300.00%-22M | -41.67%21M | -52.94%16M | ---- | -80.00%1M | 614.29%36M | 1,800.00%34M | ---- | 600.00%5M | 41.67%-7M |
| -Changes in the fair value of financial assets | ---- | -41.67%21M | ---- | ---- | ---- | 614.29%36M | ---- | ---- | ---- | 41.67%-7M |
| -Changes in the fair value of other assets | -2,300.00%-22M | ---- | -52.94%16M | ---- | -80.00%1M | ---- | 1,800.00%34M | ---- | 600.00%5M | ---- |
| Impairment and provision | ---1M | 58.54%-34M | -3.03%-34M | -6.45%-33M | --0 | -24.24%-82M | 29.79%-33M | 29.55%-31M | --0 | 47.20%-66M |
| -Other impairment is provision | ---1M | 58.54%-34M | -3.03%-34M | -6.45%-33M | --0 | -24.24%-82M | 29.79%-33M | 29.55%-31M | --0 | 47.20%-66M |
| Special items of operating profit | 12.19%2B | -1.09%-74.11B | 12.85%5.11B | -1.21%-36.87B | 28.15%1.78B | -14.53%-73.31B | 18.84%4.53B | -32.55%-36.43B | 50.49%1.39B | -84.88%-64.01B |
| Operating profit | 2,384.16%2.31B | 139.37%3.87B | 37.68%5.05B | 1,110.00%484M | -118.57%-101M | 183.53%1.62B | 53.04%3.67B | 101.56%40M | 119.37%544M | 93.87%-1.94B |
| Financing income | ---- | 168.70%309M | ---- | -47.44%41M | ---- | -76.81%115M | ---- | -72.44%78M | -61.54%55M | -3.13%496M |
| Financing cost | ---- | 29.20%-4.19B | ---- | 28.24%-2.22B | ---- | 15.34%-5.91B | ---- | 33.92%-3.09B | 23.52%-1.37B | 20.96%-6.98B |
| Share of profits of associates | ---- | 8.89%245M | ---- | 50.53%143M | ---- | 71.76%225M | ---- | 955.56%95M | ---- | 184.52%131M |
| Share of profit from joint venture company | ---- | -34.69%32M | ---- | -50.00%17M | ---- | 712.50%49M | ---- | 525.00%34M | ---- | 84.00%-8M |
| Special items of earning before tax | 32.09%177M | ---- | 6.22%393M | ---- | 139.29%134M | ---- | 112.64%370M | ---- | 229.41%56M | ---- |
| Earning before tax | 259.84%1.77B | 107.02%274M | 4,501.96%2.35B | 46.11%-1.53B | -35.78%-1.11B | 52.96%-3.9B | 101.67%51M | 59.16%-2.84B | 79.65%-816M | 79.31%-8.3B |
| Tax | ---- | -148.99%-2.23B | ---- | 76.36%-61M | ---- | -166.07%-894M | ---- | -169.35%-258M | ---- | -237.70%-336M |
| After-tax profit from continuing operations | 252.30%1.72B | 59.32%-1.95B | 1,330.98%2.27B | 48.63%-1.59B | -21.37%-1.13B | 44.44%-4.8B | 92.81%-184M | 52.93%-3.1B | 76.93%-931M | 78.34%-8.64B |
| After-tax profit from non-continuing business | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
| Earning after tax | 252.30%1.72B | 59.32%-1.95B | 1,330.98%2.27B | 48.63%-1.59B | -21.37%-1.13B | 44.44%-4.8B | 92.81%-184M | 52.93%-3.1B | 76.93%-931M | 78.34%-8.64B |
| Minority profit | 165.19%88M | 44.23%-319M | 452.17%162M | 51.36%-161M | -5.47%-135M | -28.25%-572M | -224.32%-46M | -1.53%-331M | 34.69%-128M | 82.26%-446M |
| Profit attributable to shareholders | 264.12%1.63B | 61.36%-1.63B | 1,623.91%2.1B | 48.30%-1.43B | -23.91%-995M | 48.40%-4.23B | 94.68%-138M | 55.77%-2.77B | 79.09%-803M | 78.08%-8.19B |
| Basic earnings per share | 275.00%0.07 | 42.11%-0.11 | 1,000.00%0.09 | 50.00%-0.06 | 0.00%-0.04 | 48.65%-0.19 | 91.67%-0.01 | 57.14%-0.12 | 76.47%-0.04 | 81.31%-0.37 |
| Diluted earnings per share | 275.00%0.07 | 1,000.00%0.09 | 0.00%-0.04 | 91.67%-0.01 | 76.47%-0.04 | |||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Touche Tohmatsu Limited, Deloitte China CPA Firm (Special General Partnership) | -- | -- | -- | Deloitte Touche Tohmatsu Limited, Deloitte China CPA Firm (Special General Partnership) | -- | -- | -- | PwC, PwC Zhongtian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.